test article-Pure Green-osteoarthritis of the knee

Pure Green's osteoarthritis-of-the-knee test article is a **non-specific umbrella term** for rapidly dissolvable, water-soluble sublingual cannabinoid tablet candidates evaluated for chronic pain associated with knee osteoarthritis. The registered Phase 2 program includes two distinct fixed-dose cannabinoid combinations: PG-OA-10CN, containing cannabidiol and cannabinol, and PG-OA-5TH, containing cannabidiol and tetrahydrocannabinol. The products were administered sublingually three times daily and evaluated against placebo for analgesic efficacy, knee function, stiffness, quality of life, and safety. This term should not be equated with nabiximols, which is a different cannabinoid product.

Other names

Pure Green sublingual cannabinoid tabletstest article-Pure Green-osteoarthritis of the knee